Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected Individuals
Clinical trial NCT04272242 · TERMINATED
Trial details
- NCT number
- NCT04272242
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-27
- Primary completion
- 2021-12-15
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.